IMMUNOGLOBULIN DEFICIENCIES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE; PREVALENCE AND LONG TERM EFFECT ON CLINICAL OUTCOMES

被引:0
|
作者
Koutroumpakis, Filippos
Ahsan, Maaz
Yadav, Dhiraj
Rivers, Claudia Ramos
Machicado, Jorge
Proksell, Siobhan
Johnston, Elyse
Dueker, Jeffrey
Jana, Hashash
Phillips, Anna E.
Tang, Gong
Babichenko, Dmitriy
Dunn, Michael A.
Binion, David G.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Su1946
引用
收藏
页码:S714 / S715
页数:2
相关论文
共 50 条
  • [21] Long-term clinical outcome after infliximab discontinuation in patients with inflammatory bowel disease
    Lee, Ji Min
    Kim, Yoon Jae
    Lee, Kang-Moon
    Yoon, Hyuk
    Lee, Bo-In
    Kim, Dae Bum
    Kang, Donghoon
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2018, 53 (10-11) : 1280 - 1285
  • [22] Prevalence of hepatitis B and clinical outcomes in inflammatory bowel disease patients in a viral-endemic region
    Chan, Heyson C. H.
    Wong, Vincent W. S.
    Wong, Grace L. H.
    Tang, Whitney
    Wu, Justin C. Y.
    Ng, Siew C.
    BMC GASTROENTEROLOGY, 2016, 16
  • [23] Prevalence of hepatitis B and clinical outcomes in inflammatory bowel disease patients in a viral-endemic region
    Heyson C. H. Chan
    Vincent W. S. Wong
    Grace L. H. Wong
    Whitney Tang
    Justin C. Y. Wu
    Siew C. Ng
    BMC Gastroenterology, 16
  • [24] Effect of Bariatric Surgery on Disease Outcomes in Patients With Inflammatory Bowel Disease
    Desai, Aakash
    Hashash, Jana G.
    Baker, Gianna
    Farraye, Francis A.
    Waghray, Nisheet
    Kochhar, Gursimran S.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2024, 58 (05) : 447 - 453
  • [25] Bronchiectasis in patients with inflammatory bowel disease - prevalence, predictors, and clinical characteristics
    Freund, O.
    Bar-Shai, A.
    Alkhazov, A.
    Stav, D.
    Hadad, Y.
    Perluk, T. M.
    Sror, N.
    Hirsch, A.
    Ron, Y.
    Thurm, T.
    Herling, A.
    Leibovitzh, H.
    Maharshak, N.
    Cohen, N. A.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1153 - i1153
  • [26] Prevalence of clinical and subclinical spondyloarthropathy in patients with inflammatory bowel disease.
    de Vlam, K
    De Vos, M
    Vandekerckhove, K
    Mielants, H
    Cesmeli, E
    De Keyser, F
    Cuvelier, C
    Veys, E
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S113 - S113
  • [27] The prevalence and clinical characteristics of anemia in Korean patients with inflammatory bowel disease
    Lee, Dae Sung
    Bang, Ki Bae
    Kim, Ji Yeon
    Jung, Yoon Suk
    Park, Jung Ho
    Kim, Hong Joo
    Cho, Yong Kyun
    Sohn, Chong Il
    Jeon, Woo Kyu
    Kim, Byung Ik
    Choi, Kyu Young
    Park, Dong Il
    INTESTINAL RESEARCH, 2016, 14 (01) : 43 - 49
  • [28] Prevalence of clinical and subclinical spondyloarthropathy in patients with inflammatory bowel disease.
    De Vos, M
    De Vlam, K
    Elewaut, D
    Mielants, H
    Cesmeli, E
    De Keyser, F
    Cuvelier, C
    Veys, E
    GASTROENTEROLOGY, 1998, 114 (04) : A963 - A963
  • [29] Long-term outcomes after primary infliximab treatment failure in patients with inflammatory bowel disease
    Buhl, S.
    Steenholdt, C.
    Borghede, M.
    Rasmussen, M.
    Brynskov, J.
    Thomsen, O. O.
    Ainsworth, M. A.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S287 - S288
  • [30] Long-Term Outcomes After Primary Infliximab Treatment Failure in Patients With Inflammatory Bowel Disease
    Buhl, Sine
    Steenholdt, Casper
    Borghede, Maria K.
    Rasmussen, Maria
    Brynskov, Jorn
    Thomsen, Ole
    Ainsworth, Mark A.
    GASTROENTEROLOGY, 2016, 150 (04) : S809 - S809